This action was in response to an executive order issued on August 6, 2020 aimed at protecting the public against outbreaks of emerging diseases and chemical, biological, radiological, and nuclear threats.
Immediate or delayed differences in adverse event rates were seen after generic commercialization of 3 antihypertensive drugs.
The FDA has approved the first treatment for patients with sickle cell disease in almost 20 years.
This study suggests that the main factors associated with virological success in HIV patients using ART include having an undetectable viral load and the use of 3 antiretroviral drugs.
A federal report from the CDC suggests that US hospitals are still over-prescribing antibiotics even with growing concerns of bacterial resistance.
The FDA has just approved the drug, Exondys 51, to treat patients with a mutation of the dystrophin gene amenable to exon 51 skipping in DMD.
According to Mylan, the first generic version of EpiPen® will be distributed in several weeks in an attempt to further lower the costs of attaining this life-saving medication.
The pharmaceutical company has outlined steps to lower the financial burden of acquiring their products after price hike.
The US Food and Drug Administration (FDA) has approved the first generic version of Tamiflu®.
Millions of people today take statins to help lower their cholesterol level. Currently statins are prescribed to patients based on their future risk of cardiovascular disease – mainly driven by age – which excludes many individuals who may benefit from them.
